Transsynaptic delivery of nanoparticles to the central auditory nervous system.
Saved in:
| Title: | Transsynaptic delivery of nanoparticles to the central auditory nervous system. |
|---|---|
| Authors: | Praetorius, >Mark (AUTHOR), Brunner, Christian (AUTHOR), Lehnert, Bernhard (AUTHOR), Klingmann, Christoph (AUTHOR), Schmidt, Helmut (AUTHOR), Staecker, Hinrich (AUTHOR), Schick, Bernhard (AUTHOR) |
| Source: | Acta Oto-Laryngologica. May2007, Vol. 127 Issue 5, p486-490. 5p. 9 Color Photographs, 1 Graph. |
| Subjects: | Inner ear diseases, Nanoparticles, Silica, Acoustic nerve, Nervous system, Hair cells |
| Abstract: | Conclusion. Silica nanoparticles may serve as a nonviral delivery system to the sensory hair cells, spiral ganglion cells within the cochlea, and the vestibular organ, as well as the cochlear nucleus. Objectives. At present there are no targeted therapeutics for inner ear disease. A variety of viral vector systems have been tested in the inner ear with variable efficacy but they are still not regarded as safe systems for inner ear delivery. Nanoparticles are a nonviral method of delivering a variety of macromolecules that potentially can be used for delivery within the auditory system. In this study, we evaluated the distribution and safety of nanoparticles in the inner ear. Materials and methods. Cy3-labeled silica nanoparticles were placed on the round window membrane of adult mice. Hearing thresholds were determined after nanoparticle delivery by auditory brainstem responses (ABRs). Distribution of particles was determined by histological evaluation of the cochlea, vestibular organs, and brain stem. Results. Fluorescent microscopy demonstrated Cy3-labeled nanoparticles signals in the sensory hair cells and the spiral ganglion neurons of both the treated and contralateral inner ears. Additionally, the distal part of the central auditory pathway (dorsal cochlear nucleus, superior olivary complex) was found to be labeled with the Cy3-linked silica nanoparticles, indicating a retrograde axonal transport. No hearing loss or inflammation was noted in the treated cochlea. [ABSTRACT FROM AUTHOR] |
| Copyright of Acta Oto-Laryngologica is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
